Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Eylea

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

Eylea growth closes the gap with Lucentis

Eylea growth closes the gap with Lucentis Bayer/Regeneron’s drug eye disease drug set for blockbuster status. Bayer and Regeneron's eye disease therapy Eylea is on course to break into the blockbuster club this year, after ... Armed with new indications such as diabetic macular edema (DME),

Trials of Roche's new blindness candidate now underway

Trials of Roche's new blindness candidate now underway While multiple therapies exist for wet AMD - Lucentis competes in the market with Bayer's Eylea (aflibercept) as well as off-label use of Roche's cancer drug Avastin (bevacizumab) - there

Top biotech firms saw sales jump in 2014

Top biotech firms saw sales jump in 2014 Dion explains: “Regeneron's sales grew by 34% in 2014, as the company continued its commercialisation of [eye disease drug] Eylea (afilibercept) to markets outside the US, including for the treatment

The BMJ weighs in on Avastin/Lucentis debate

The BMJ weighs in on Avastin/Lucentis debate Currently, General Medical Council guidance and European drug licensing laws say that Lucentis (ranibizumab), developed by Novartis and Roche, and Bayer/Regeneron's Eylea (aflibercept) - that are both approved to treat ... ahead of Lucentis and Eylea for

Bayer's Eylea cleared for wider use in Europe

Bayer's Eylea cleared for wider use in Europe The European Commission has approved Eylea (aflibercept) for the treatment of patients with macular oedema secondary to retinal vein occlusion. ... Eylea is being co-developed by Bayer and Regeneron, with Bayer holding exclusive marketing rights to the

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...